Good morning, and welcome to the Akebia Therapeutics R&D Day. [Operator Instructions] As a reminder, this call is being recorded, and a replay will be made available on the Akebia website following ...

To address these critical safety requirements, BETMAT Biotechnology LLC has released a specialized operational guide focused ...

Why Enveda, Faeth Therapeutics, Gilgamesh Pharma, and Argo Biopharma are among the most innovative companies in biotech right ...

A randomized trial led by Lilia Cervantes, MD, MSc, professor of hospital medicine at the University of Colorado Anschutz School of Medicine, has found that a culturally tailored intervention helped ...

On World Kidney Day, Newsweek explores how one country is testing whether early detection can slow a global epidemic.

Arch Biopartners announces SM begins patient dosing in phase II CS-AKI trial of LSALT peptide: Toronto Monday, March 23, 2026, 18:00 Hrs [IST] Arch Biopartners Inc. (Arch) announc ...

Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that St. Michael’s Hospital (SMH), part of Unity Health Toronto, has commenced patient dosing in ...

The Royal Academy of Engineering has shortlisted 16 innovators for the 2026 Africa Prize for Engineering Innovation. The Africa Prize, which is part funded by the UK’s Department for Science, ...

A new study from researchers at UC Berkeley and UC Santa Cruz suggests models will disobey human commands to protect their ...

The dialysis centre at the Loknete Eknathrao Gaikwad Urban Health Centre in Dharavi — commonly known as Chota Sion Hospital — is set to reopen, bringing much-needed relief to patients dependent on ...

Having a primary care physician reduces emergency department (ED) use among patients with end-stage kidney disease receiving ...

Scientists at Tufts have created a powerful 3D model of nasal tissue that reveals surprising new insights into how our sense of smell regenerates and why it sometimes fades. Contrary to past ...